In a development that is drawing attention across the clinical microbiology community, physicians in Germany have reported the first known isolation of Enterococcus thailandicus from respiratory samples in a human patient, a finding that expands the documented clinical footprint of an obscure bacterial species that was, until very recently, virtually unknown as a human pathogen. The case, published in the open-access journal New Microbes and New Infections, describes a 73-year-old critically ill man in whom the organism was recovered not once but twice, first from a drained intra-abdominal abscess and later from bronchial secretions during a severe nosocomial pneumonia, where it appeared alongside the opportunistic fungus Aspergillus fumigatus. The report, accompanied by a systematic mini-review of all published human cases, arrives at a moment of growing evidence that this overlooked microbe may be an under-recognized player in polymicrobial, healthcare-associated infections.
Enterococci are facultatively anaerobic, gram-positive cocci that dwell harmlessly in the gastrointestinal and genitourinary tracts of humans and animals, where they form part of the normal commensal microbiota. Yet the genus harbors a well-documented dual identity. Under the right circumstances, particularly in healthcare settings, enterococci can behave as formidable opportunistic pathogens, ranking among the leading causes of urinary tract infections, intra-abdominal infections, bacteremia, and infective endocarditis. Two species, Enterococcus faecalis and Enterococcus faecium, account for the overwhelming majority of these infections and are notorious for their capacity to acquire and disseminate antimicrobial resistance, including vancomycin resistance. The remaining dozens of species in the genus remain poorly characterized, and their pathogenic potential is largely a matter of conjecture. Enterococcus thailandicus sits squarely in this understudied category. First described in 2008 from a fermented sausage known locally as “mum” in Thailand, the species has undergone taxonomic refinement since, with later work establishing it as a senior subjective synonym of the previously named “E. sanguinicola.” Despite this formal clarification, its ecological niche and capacity to cause human disease have remained murky, with experimental and genomic analyses revealing a heterogeneous profile in which some isolates lack classical virulence determinants while others carry features that raise genuine safety concerns.
The clinical record for this species is strikingly thin. Before the current report, only a handful of human isolations had ever been described worldwide. The first came from Belgium in 2023, when researchers identified E. thailandicus in peritoneal fluid from a patient with fecal peritonitis secondary to a perforated sigmoid diverticulum, as part of a polymicrobial infection. Subsequent detections have trickled in from Romania, Spain, Germany, Japan, and Taiwan, encompassing an unusual breadth of specimen types: blood and urine in a Japanese case of bacteremia in an immunosuppressed patient with Crohn’s disease; rectal swabs recovered on chromogenic media during routine vancomycin-resistant enterococci screening in an intensive care setting; urine in a separate German report; tissue cultures from debridements in a patient with severe lower extremity trauma; and bile and peritoneal fluid from patients with acute cholecystitis and small bowel perforation. Genomic analysis of one recent isolate has even suggested that E. thailandicus may represent a potential new contributor to enterococcal virulence and antimicrobial resistance, a finding that has sharpened interest in a species once considered little more than a food-associated curiosity.
The new case began, as many abdominal emergencies do, with acute and severe abdominal pain. A 73-year-old man presented to the emergency department, where contrast-enhanced computed tomography revealed pneumoperitoneum, the presence of free air within the abdominal cavity, a classic radiological sign of a perforated hollow viscus. Emergency surgery was undertaken, and intraoperatively the surgical team identified a perforated duodenal ulcer, which was resected and the defect closed. Histopathological examination of the resected tissue confirmed extensive ulceration of the duodenal mucosa with full-thickness involvement of the intestinal wall and associated acute peritonitis. Microscopic analysis showed destruction of the villi and crypts, with dense infiltration by neutrophils and a fibrinous exudate, the histological signature of an acute penetrating ulcer. Testing for Campylobacter-like organisms, which can produce similar mucosal pathology, was negative.
The postoperative course was anything but straightforward. On the third day after surgery, the patient developed melena, black tarry stools indicating upper gastrointestinal bleeding, accompanied by a decline in hemoglobin. Upper gastrointestinal endoscopy revealed additional duodenal ulcerations, including a lesion classified as Forrest IIa, a designation indicating a visible non-bleeding vessel that carries a high risk of rebleeding. Endoscopists managed the lesion with an over-the-scope clip device, a modern mechanical hemostasis technique that deploys a large-capacity clip over the endoscope tip to compress the ulcer margin and seal the bleeding vessel.
Two weeks after the index operation, with inflammatory markers persistently rising, the clinical team obtained repeat CT imaging. The scan disclosed a two by four centimeter subhepatic collection, an abscess-like fluid accumulation beneath the liver, which was drained percutaneously. Microbiological analysis of the drainage fluid identified Enterococcus thailandicus, grown on Luria-Bertani medium after 24 hours of incubation at 37 degrees Celsius. Antimicrobial susceptibility testing showed the isolate was sensitive to vancomycin, the glycopeptide antibiotic that serves as a benchmark agent against resistant gram-positive cocci, and targeted antimicrobial therapy was initiated accordingly.
The patient’s troubles, however, were not confined to the abdomen. His intensive care course was further complicated by critical illness polyneuropathy, a debilitating neuromuscular complication of prolonged critical illness, and by pneumonia requiring extended mechanical ventilation, ultimately necessitating tracheostomy and vasopressor support to maintain blood pressure. During bronchoscopy, physicians visualized diffuse purulent secretions and, remarkably, raised, cream-colored pseudomembranes lining the airways, a striking endoscopic appearance suggestive of exuberant inflammatory or infectious involvement of the bronchial tree. While on mechanical ventilation the patient initially required a fraction of inspired oxygen of 50 percent and a positive end-expiratory pressure of 9 millibar, parameters indicating moderately severe respiratory compromise. Microbiological analysis of the bronchial secretions identified E. thailandicus in addition to Aspergillus fumigatus, the mold responsible for invasive aspergillosis in immunocompromised and critically ill hosts. The clinical team responded with combination antimicrobial and antifungal therapy, administering vancomycin against the bacterial isolate and isavuconazole, a newer triazole antifungal, against the Aspergillus. The strategy worked. The patient improved clinically, invasive ventilation parameters were de-escalated, and over the following weeks he was progressively weaned from the ventilator and from vasopressor support, ultimately being transferred to a rehabilitation facility after three weeks of intensive care.
The authors emphasize that their report expands the clinical spectrum of E. thailandicus in two distinct directions. First, it constitutes, to their knowledge, only the third report of the organism recovered from an intra-abdominal infected collection associated with gastrointestinal perforation, reinforcing an emerging pattern linking the species to breaches of the intestinal barrier. Second, and more significantly, it represents the first isolation of E. thailandicus from respiratory material in a human host, in the context of severe nosocomial pneumonia. Whether the organism was a true pulmonary pathogen, a contributor to the polymicrobial airway flora of a ventilated patient, or a colonizer is difficult to establish with certainty, a familiar challenge in the microbiology of critically ill patients whose airways are colonized by a shifting cast of opportunists. Nonetheless, the recovery of the organism from purulent bronchial secretions, in combination with a plausible pathogen and a corresponding clinical response to targeted therapy, lends weight to its potential pathogenic role.
The accumulating reports also raise a provocative question: could E. thailandicus play a role in gastrointestinal pathology itself? The recurrence of the species in intra-abdominal infections following gastrointestinal perforation is suggestive, and experimental data from animal models offer a tantalizing parallel. In pigs, certain strains of the organism have been shown to induce intestinal alterations, including villous atrophy and crypt changes, findings that echo the mucosal destruction observed in duodenal ulcers. The authors are careful, however, to stress that causality remains entirely speculative, and notably, the intestinal alterations described in the animal model were not observed in their patient. The safety assessment literature surrounding E. thailandicus remains divided, particularly given the species’ historical association with fermented foods and proposals for its technological or probiotic use, applications that have long been controversial within the genus because some enterococcal strains harbor virulence-associated traits or antimicrobial resistance determinants requiring careful strain-level evaluation.
What emerges most clearly from the German case and its accompanying literature review is a methodological point with practical consequences for clinical microbiology laboratories. The rarity of published E. thailandicus detections almost certainly reflects, at least in part, under-recognition. In polymicrobial infections, where multiple organisms compete for the attention of diagnosticians, and in laboratories where advanced identification methods such as matrix-assisted laser desorption ionization mass spectrometry or whole-genome sequencing are not routinely applied to every isolate, unusual species can easily be misidentified as more familiar enterococci or dismissed as insignificant commensal contaminants. The growing list of documented clinical isolates, spanning peritoneal fluid, blood, urine, bile, rectal swabs, wound debridements, and now respiratory secretions, suggests that the true incidence of E. thailandicus infection may be considerably higher than the literature implies.
The case also adds to a limited but steadily growing body of evidence that this food-associated species can act as an opportunistic pathogen in vulnerable hosts. While its virulence appears low compared with its more notorious cousins E. faecalis and E. faecium, the trajectory of reports over the past three years, from the first Belgian description in 2023 through a burst of publications in 2025 and 2026, indicates that clinicians and microbiologists are increasingly encountering the organism as identification technologies improve and awareness spreads. Continued reporting and accurate, species-level identification of rare enterococci, the authors argue, are essential to improving understanding of their clinical relevance, particularly in polymicrobial infections and in critically ill patients whose compromised defenses lower the threshold for even weakly virulent organisms to cause disease. For now, E. thailandicus serves as a reminder that the microbial world harbored within and around us still contains species capable of surprising the physicians who meet them, and that in the intensive care unit, even the most obscure commensal can become a clinically meaningful adversary when the right combination of surgical catastrophe, invasive devices, and immune vulnerability converges.
Subject of Research: First isolation of Enterococcus thailandicus from respiratory samples in a critically ill patient, with a review of prior human cases
Subject of Research: Medicine
Article Title: Enterococcus thailandicus identified in respiratory samples in a critically ill patient: clinical report and mini review
Article References: Mester, P., Schmid, S., Kandulski, A., Gschwendtner, H., Weber, F., Müller, M., & Pavel, V. (2026). Enterococcus thailandicus identified in respiratory samples in a critically ill patient: clinical report and mini review. New Microbes and New Infections, 73, Article 101815. https://doi.org/10.1016/j.nmni.2026.101815
Image Credits: AI Generated
DOI: 10.1016/j.nmni.2026.101815
Keywords: Enterococcus thailandicus, opportunistic pathogen, respiratory infection, nosocomial pneumonia, duodenal ulcer perforation, intra-abdominal infection, polymicrobial infection, vancomycin, critically ill patient, clinical microbiology, emerging pathogen, case report
Cite Scienmag News
APA MLA Chicago
Morgan Morrow. (September 8, 2026). Rare bacterium Enterococcus thailandicus detected in critically ill patient’s respiratory samples. Scienmag. https://scienmag.com/rare-bacterium-enterococcus-thailandicus-detected-in-critically-ill-patients-respiratory-samples/
Morgan Morrow. “Rare bacterium Enterococcus thailandicus detected in critically ill patient’s respiratory samples.” Scienmag, 8 September 2026, https://scienmag.com/rare-bacterium-enterococcus-thailandicus-detected-in-critically-ill-patients-respiratory-samples/. Accessed 8 September 2026.
Morgan Morrow. “Rare bacterium Enterococcus thailandicus detected in critically ill patient’s respiratory samples.” Scienmag. September 8, 2026. https://scienmag.com/rare-bacterium-enterococcus-thailandicus-detected-in-critically-ill-patients-respiratory-samples/
Copy citation Download RIS
Tags: clinical microbiologycritically ill patientdetection in respiratory samplesemerging bacterial pathogensemerging infectious diseaseEnterococcus thailandicusgastrointestinal microbiotagram-positive coccihealthcare-associated infectionshuman clinical caseshuman microbiotainfection case reportsmicrobiologynosocomial pneumoniaopportunistic bacterial pathogenopportunistic bacterial pathogenspolymicrobial infectionsrespiratory infectionrespiratory infectionsrespiratory sample analysis
